Recent developments

at Tullis and our portfolio companies

News

Keeping you current on new and follow-on investments, portfolio product and service milestones, publications and events, management and board transitions, and other developments in Tullis funds.

October

16

ATEC Announces Closing Of Public Stock Offering And Full Exercise Of Underwriters’ Option To Purchase Additional Stock

Total gross proceeds of approximately $115.0 million, before underwriting discounts and commissions and estimated offering...

14

ATEC Announces Pricing Of Public Offering Of Common Stock

11,428,570 shares of common stock at a public offering price of $8.75 per share Alphatec...

13

ATEC Announces Proposed Public Offering Of Common Stock

CARLSBAD, Calif., Oct. 13, 2020 (GLOBE NEWSWIRE) — Alphatec Holdings, Inc. (“ATEC”) (NASDAQ: ATEC), a provider of innovative...

13

electroCore Provides Business Update and Select Financial Guidance

Third quarter 2020 Revenue expected to exceed $1 million, representing an increase of greater than 35% sequentially...

12

New Data Demonstrates Economic Benefit of Exagen’s AVISE® Lupus Test for Payors

Findings support the clinical need for an improved SLE diagnostic test SAN DIEGO, Oct. 12,...

8

Alphatec Pops 21% On 3Q Sales Guidance Beat; Street Says Buy

The Strong Buy analyst consensus boasts 5 unanimous Buy ratings. Alphatec (ATEC) expects third-quarter...

7

ATEC Announces Preliminary Third Quarter 2020 Financial Results

Third quarter U.S. revenue expected to grow over 40% Eighth consecutive quarter of double-digit revenue growth Revenue per case expands on strong pull- through from SafeOp neuromonitoring and new...

6

ATEC Announces Commercial Release Of Distinct, Comprehensive TLIF Approach

Sigma TLIF Access System, InVictus Modular Fixation System, and SafeOp Neural InformatiX System Clinically Differentiate the...

5

ATEC Announces Novel PTP Approach

Over 500 initial surgeries successfully performed Advances lateral surgery with a more predictable, more...

1

electroCore, Inc. Announces Extension of NHS England’s Innovation and Technology Payment (ITP) Program to Fund Continued Use of gammaCore™ in England

ITP program providing reimbursement for gammaCore™ extended to March. 31, 2021 with option for additional...

29

TriSalus Life Sciences Appoints Steven Katz, M.D., Chief Medical Officer

Renowned surgeon, clinician, and researcher to advance work to combine novel immuno-oncology therapies with...

29

Exagen Inc. Announces Agreement with Provider Network of America

Expanding Access for AVISE® Tests to 8 Million Members SAN DIEGO, Sept. 29, 2020 (GLOBE NEWSWIRE)...

Recent developments

News

October

16

ATEC Announces Closing Of Public Stock Offering And Full Exercise Of Underwriters’ Option To Purchase Additional Stock

October

14

ATEC Announces Pricing Of Public Offering Of Common Stock

October

13

ATEC Announces Proposed Public Offering Of Common Stock

October

13

electroCore Provides Business Update and Select Financial Guidance

October

12

New Data Demonstrates Economic Benefit of Exagen’s AVISE® Lupus Test for Payors

October

8

Alphatec Pops 21% On 3Q Sales Guidance Beat; Street Says Buy

October

7

ATEC Announces Preliminary Third Quarter 2020 Financial Results

October

6

ATEC Announces Commercial Release Of Distinct, Comprehensive TLIF Approach

October

5

ATEC Announces Novel PTP Approach

October

1

electroCore, Inc. Announces Extension of NHS England’s Innovation and Technology Payment (ITP) Program to Fund Continued Use of gammaCore™ in England

September

29

TriSalus Life Sciences Appoints Steven Katz, M.D., Chief Medical Officer

September

29

Exagen Inc. Announces Agreement with Provider Network of America